Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis
2023: Ozempic, 2nd Biggest Bank Collapse, AlphaFold, FDA Approval of Gene Therapy and CRISPR Gene Editing,….
Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance
Helix® Laboratory Platform Granted the First and Only FDA Authorization for a Whole Exome Sequencing Platform